CD44 and hepatocellular carcinoma: In line with this, the STAT3/IL-6 pathway was reported to be involved in the increased frequency of CD44+ hepatocellular carcinoma (HCC) stem cells, when co-cultured with TAMs isolated from HCC-bearing patients.